Physician

Sarah Fantus, M.D.

According to 2025 Medicare claims, Sarah Fantus, M.D. (NPI: 1437577285) practices rheumatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is KANSAS CITY PHYSICIAN PARTNERS INC (NPI: 1831531466; TIN: 463233706) and primary practice location at 64111-3315. Fantus is affiliated with the Aledade 98 MO MSSP Enhanced (ACO ID: A4998), Centrus Health of Kansas LLC (ACO ID: A5305), and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Fantus' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 318 traditional Medicare patients, billed 61,003 HCPCS/CPT codes, and received $851,444 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,497 prescription claims across 292 beneficiaries totaling $1,383,422 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2017 DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $14,733 to $851,444. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,285 to $1,383,422. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	86	158	$14,733
2021	194	1,019	$53,010
2022	182	3,420	$61,453
2023	252	53,263	$682,686
2024	318	61,003	$851,444

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	26	75	$3,285
2016	N/R	24	$843
2017	14	43	$4,409
2018	19	46	$4,499
2019	51	221	$10,412
2020	63	282	$91,133
2021	118	512	$300,590
2022	145	633	$814,189
2023	209	850	$405,566
2024	292	1,497	$1,383,422

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$35
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	177	322	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	166	253	$12
36415	Insertion of needle into vein for collection of blood sample	146	284	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	121	233	$8
86140	Measurement c-reactive protein for detection of infection or inflammation	130	216	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	27	756	$363,428
Enbrel Sureclick	Etanercept	36	1,008	$273,490
Xeljanz Xr	Tofacitinib Citrate	24	720	$133,120
Rinvoq	Upadacitinib	20	600	$128,254
Forteo	Teriparatide	11	308	$47,148

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Sarah Fantus, M.D.?

Tedicare shows public-source Medicare data for Sarah Fantus, M.D. (NPI 1437577285), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah Fantus, M.D. have ACO affiliation data?

Sarah Fantus, M.D. is shown with ACO affiliation data for Aledade 98 MO MSSP Enhanced (MSSP, ACO ID A4998), Centrus Health of Kansas LLC (MSSP, ACO ID A5305), and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Sarah Fantus, M.D.?

Sarah Fantus, M.D. is linked to KANSAS CITY PHYSICIAN PARTNERS INC (billing NPI 1831531466) in the available physician profile data.

Does Sarah Fantus, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.